Diagnostik und Ausschluss des hereditären Angioödems

[1]  M. Maurer,et al.  Hereditäres Angioödem: Update zu verfügbaren Therapieoptionen , 2010 .

[2]  L. Bielory,et al.  Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool. , 2010, Allergy and asthma proceedings.

[3]  William H. Yang,et al.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.

[4]  J. Bernstein,et al.  Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. , 2010, The New England journal of medicine.

[5]  A. Sheffer,et al.  Ecallantide for the treatment of acute attacks in hereditary angioedema. , 2010, The New England journal of medicine.

[6]  P. Pundir,et al.  Comparison of the inhibitory effects of resveratrol and tranilast on IgE, 48/80 and substance P dependent-mast cell activation , 2010, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

[7]  T. Craig,et al.  Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2) , 2010, Expert review of clinical immunology.

[8]  M. Maurer,et al.  Erfolgreiche Behandlung des hereditären Angioödems mit dem Bradykinin‐B2‐Rezeptor‐Antagonisten Icatibant , 2010 .

[9]  Diego S. Fernández Romero,et al.  Angioedema hereditario: Historia familiar y manifestaciones clínicas en 58 pacientes , 2009 .

[10]  A. Bygum,et al.  Hereditary angio‐oedema in Denmark: a nationwide survey , 2009, The British journal of dermatology.

[11]  T. Zuberbier,et al.  Successful treatment of hereditary angioedema with bradykinin B2‐receptor antagonist icatibant , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[12]  T. Craig,et al.  Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. , 2009, Allergy and asthma proceedings.

[13]  T. Arita,et al.  Computed tomography of the gastrointestinal manifestation of hereditary angioedema , 2008, Radiation Medicine.

[14]  D. N. Patel,et al.  Hereditary angioedema with normal C1 inhibitor. , 2008, The American journal of medicine.

[15]  Pedro Mejia,et al.  Biological activities of C1 inhibitor. , 2008, Molecular immunology.

[16]  H. Joller-jemelka,et al.  Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. , 2008, Journal of immunological methods.

[17]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[18]  G. Kojda,et al.  Nonallergic angioedema: role of bradykinin , 2007, Allergy.

[19]  M. Mohammadi,et al.  An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio‐oedema , 2007, Clinical and experimental immunology.

[20]  P. Schlattmann,et al.  Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). , 2007, The Journal of allergy and clinical immunology.

[21]  H. Farkas,et al.  Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks , 2007, Transfusion.

[22]  S. Cichon,et al.  Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. , 2006, American journal of human genetics.

[23]  M. Cicardi,et al.  Angioedema without urticaria: a large clinical survey , 2006, Canadian Medical Association Journal.

[24]  A. Eckardt,et al.  Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency , 2006, The American Journal of Gastroenterology.

[25]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[26]  M. Tang,et al.  Hereditary angio‐oedema in children: A management guideline , 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[27]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[28]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[29]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[30]  M. Cicardi,et al.  C1 inhibitor concentrate therapy in 473 patients with hereditary and acquired angioedema , 2004 .

[31]  H. Griffiths,et al.  Normal complement C4 values do not exclude hereditary angioedema , 2004, Journal of Clinical Pathology.

[32]  K. Dirks,et al.  Sonographie beim hereditären Angioödem: Typische Befunde anhand dreier Kasuistiken , 2001 .

[33]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[34]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[35]  H. Hintner,et al.  Untersuchungen zum hereditären Angioödem im deutschsprachigen Raum , 1998, Der Hautarzt.

[36]  A. Malbrán,et al.  [Hereditary angioedema. Family history and clinical manifestations in 58 patients]. , 2009, Medicina.

[37]  A. Davis.  The pathophysiology of hereditary angioedema. , 2005, Clinical immunology.

[38]  P. Keith,et al.  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access , 2022 .

[39]  K. Binkley.  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access Factor XII mutations, estrogen-dependent , 2022 .